Chinese biotech firms brace for profit hit from Trump tariffs, US funding bill
Efforts to expand sales of high-value products in China and non-US markets would cushion the blow, analysts say.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
